Public spending for illegal drug and alcohol treatment in hospitals: an EU cross-country comparison

Abstract

BackgroundIn view of the current economic crisis and the resulting austerity measures being implemented by governments across Europe, public expenditure for substance abuse treatment has increasingly become a subject of discussion. An EU cross-country comparison would allow an estimation of the total amount of public resources spent on substance abuse treatment, compare various substance abuse treatment funding options, and evaluate the division of expenditures between alcohol and illegal drugs. The purpose of this study is to estimate the public spending of EU countries for alcohol and illegal drug abuse treatment in hospitals.MethodsOur study uses a uniform methodology in order to enable valid cross-national comparisons. Our data are drawn from the Eurostat database, which provides anno 2010 data on government spending for the treatment of illegal drug and alcohol abuse in 21 EU member states. The cross-country comparison is restricted to hospitals, since data were unavailable for other types of treatment providers. The systematic registration of in- and outpatient data is essential to monitoring public expenditures on substance abuse treatment using international databases.ResultsTotal public spending for hospital-based treatment of illegal drug and alcohol abuse in the 21 EU member states studied is estimated to be 7.6 billion euros. Per capita expenditures for treatment of illegal drug abuse vary, ranging from 0.1 euros in Romania to 13 euros in Sweden. For alcohol abuse, that figure varied from 0.9 euros in Bulgaria to 24 euros in Austria. These results confirm other studies indicating that public expenditures for alcohol treatment exceed that for illegal drug treatment.ConclusionsMultiple factors may influence the number of hospital days for alcohol or illegal substance abuse treatment, and expenditures fluctuate accordingly. In this respect, we found a strong correlation between gross domestic product (GDP) per capita and public expenditures per hospital day. The prevalence of problematic (illegal or legal) drug use in a country did not correlate significantly with the number of hospital days. Other factors must be included in the analysis of public expenditures for the treatment of substance abuse, such as the drug policy in a given country and the social norms regarding alcohol consumption.

Multiple Substance Use Patterns and Its Relationship with Imprisonment in a High-Risk Group of Iranian Adults

“… 7 In Europe, 11% of disability-adjusted life years are due to alcohol and illicit drugs. 8 Moreover, the misuse of substances such as cannabis, amphetamines, opioids, and tobacco is increasing and is a major threat to public health in Asian countries. 9 , 10 Opium has also been widely used for a long time in Iran, so opium use in this country is three times higher than the global average.…”

Interpersonal problems of alcohol use disorder patients undergoing a physical exercise intervention – a randomised controlled trial

“…The psychosocial and physical consequences of alcohol use disorder (AUD) are far-reaching (Nutt, King, & Phillips, 2010). Even though AUD can be treated, the costs are high, the outcome modest and there is a high relapse rate during the first year after treatment (Cutler & Fishbain, 2005;Lievens, van der Laenen, & Christiaens, 2014;Miller & Willbourne, 2002).…”

Tendencias en la hospitalización psiquiátrica por alcohol y drogas en Castilla y León entre 2005 y 2015

“…Las limitaciones de ambos métodos hacen que la combinación e integración de los mismos sea una estrategia común para obtener una imagen más clara sobre este problema (Castiglioni, Borsotti, Senta y Zuccato, 2015). Los países de la U. E. informaron de más de 161000 altas hospitalarias por trastornos mentales y del comportamiento debido al uso de drogas ilegales y otras 707000 por consumo de alcohol en 2010 (Lievens, Vander Laenen y Christiaens, 2014). En Europa, la mayoría de los tratamientos de las drogodependencias se prestan en régimen ambulatorio.…”